Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.46 CAD | -1.60% | -0.40% | +123.64% |
Apr. 22 | HC Wainwright Starts Cardiol Therapeutics With Buy Rating, $9 Price Target | MT |
Apr. 01 | Cardiol Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Equities
- CRDL Stock
- Revisions Cardiol Therapeutics Inc.